A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology

By afschroeder • August 3, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology. Heart Rhythm. 2025 Aug;22(8):e492-e499. doi: 10.1016/j.hrthm.2025.02.038. Epub 2025 Feb 26. PMID: 40021073; PMCID: PMC12317828.

Tags: Biomarker, Cardiology/Epi, Cedars Sinai DoM, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, Surrogate end point, surrogate marker

Heart failure and atrial fibrillation prediction from non-gated chest CT scans using AI-based cardiac chamber volumetry: an AI-CVD study within the multi-ethnic study of atherosclerosis (MESA)

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]

The clinical significance of baseline lung allograft dysfunction in single and bilateral lung transplant recipients

Lari SM, Liang H, Dadfar B, Zhou J, Kim J, Sayah D, Der Hovanessian A, Saggar R, Shino MY, Turner G, Amubieya O, Haddad T,[...]

Echocardiographic estimates of pulmonary artery acceleration time and mortality risk in older adults

Nations JA, Mordini FE, Khosla R, Lam PH, Frishman WH, Aronow WS, Bytyçi I, Böhm M, Aldabain L, Vyas K, Mashaal H, Zhang S, Morgan[...]